Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, Thomas W.·2005·Nature Reviews Immunology
DOI 10.1038/nri1602
Cited by (742)
Items 101–200 of 742
- Self‐initiated use of topical cannabidiol oil for epidermolysis bullosaMalcolm Pyles Chelliah, Zachary A. Zinn, Phoung Khuu, Joyce M. C. Teng · 2018 · Pediatric Dermatology
- Effects of Cannabinoids on T-cell Function and Resistance to InfectionToby K. Eisenstein, Joseph J. Meissler · 2015 · Journal of Neuroimmune Pharmacology
- Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in ratsM. Sanson, Lionel P. Bueno, Jean Fioramonti · 2006 · Neurogastroenterology & Motility
- Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol.DeLong, Gerald T., Wolf, Carl E., Poklis, Alphonse, Lichtman, Aron H. · 2010 · Drug and Alcohol Dependence
- Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent MannerAndréa Paradisi, Nicoletta Pasquariello, Daniela Barcaroli, Mauro Maccarrone · 2007 · Journal of Biological Chemistry
- Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liverAriane Mallat, Sophie Lotersztajn · 2007 · American Journal of Physiology-Gastrointestinal and Liver Physiology
- Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolaseSándor Bátkai, Mohanraj Rajesh, Partha Mukhopadhyay, György Haskó, Lucas Liaudet, Benjamin F. Cravatt, Anna Csiszár, Zoltan I. Ungvari, Pál Pacher · 2007 · American Journal of Physiology-Heart and Circulatory Physiology
- Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healingLinlin Wang, Rui Zhao, Jiao-Yong Li, Shanshan Li, Min Liu, Meng Wang, Meng-Zhou Zhang, Wenwen Dong, Shukun Jiang, Miao Zhang et al. · 2016 · European Journal of Pharmacology
- Epigenetic control of skin differentiation genes by phytocannabinoidsMariangela Pucci, Cinzia Rapino, Andrea Di Francesco, Enrico Dainese, Claudio D’Addario, Mauro Maccarrone · 2013 · British Journal of Pharmacology
- Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short ReviewMarta Kruk-Słomka, Agnieszka Dzik, Barbara Budzyńska, Grażyna Biała · 2016 · Molecular Neurobiology
- Pharmacological and toxicological activities of α-humulene and its isomers: A systematic reviewGiovana Mendes de Lacerda, Maysa de Oliveira Barbosa, Maria Janice Pereira Lopes, Gyllyandeson de Araújo Delmondes, Daniel Souza Bezerra, Isaac Moura Araújo, Cícero Damon Carvalho de Alencar, Henrique Douglas Melo Coutinho, Laisla Rangel Peixoto, José Maria Barbosa‐Filho et al. · 2021 · Trends in Food Science & Technology
- Cannabinoid receptor activation leads to massive mobilization of myeloid‐derived suppressor cells with potent immunosuppressive propertiesVenkatesh L. Hegde, Mitzi Nagarkatti, Prakash S. Nagarkatti · 2010 · European Journal of Immunology
- Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics DevelopmentThuy Nguyen, Brian F. Thomas, Yanan Zhang · 2019 · Current Topics in Medicinal Chemistry
- Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanismKazuhide Hayakawa, Kenichi Mishima, Keiichi Irie, Mai Hazekawa, Shohei Mishima, Masayuki Fujioka, Kensuke Orito, Nobuaki Egashira, Shutaro Katsurabayashi, Kotaro Takasaki et al. · 2008 · Neuropharmacology
- Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and StrokeMing Zhang, Billy R. Martin, Martin W. Adler, Raj J. Razdan, Weimin Kong, Doina Ganea, Ronald F. Tuma · 2009 · Journal of Neuroimmune Pharmacology
- Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel SyndromeWong, Banny S., Camilleri, Michael, Busciglio, Irene, Carlson, Paula, Szarka, Lawrence A., Burton, Duane, Zinsmeister, Alan R. · 2011 · Gastroenterology
- Peripherally restricted CB1 receptor blockersRobert J. Chorvat · 2013 · Bioorganic & Medicinal Chemistry Letters
- Cannabinoids in the Pathophysiology of Skin InflammationCristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, Andreea-Elena Scheau, Daniel Octavian Costache, Carolina Constantin, Daniela Cornelia Călina, Constantin Căruntu, Raluca Simona Costache, Ana Căruntu · 2020 · Molecules
- TRP channels as novel players in the pathogenesis and therapy of itchTamás Bı́ró, Balázs István Tóth, Rita Marincsák, Nóra Dobrosi, Tamás Géczy, Ralf Paus · 2007 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cellsValerio Chiurchiù, Mirko Lanuti, Marco De Bardi, Luca Battistini, Mauro Maccarrone · 2014 · International Immunology
- Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensationMichael Camilleri, Paula Carlson, Sanna McKinzie, April Grudell, Irene A. Busciglio, Duane D. Burton, Kari L. Baxter, Michael D. Ryks, Alan R. Zinsmeister · 2007 · American Journal of Physiology-Gastrointestinal and Liver Physiology
- Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediatorX Zhang, Yehoshua Maor, Wang Jf, George Kunos, JE Groopman · 2010 · British Journal of Pharmacology
- Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosisEstrella García González, Enrico Selvi, Epifania Balistreri, Alfiya Akhmetshina, Katrin Palumbo, Sauro Lorenzini, Pietro Enea Lazzerini, Cinzia Montilli, Pier Leopoldo Capecchi, Monica Lucattelli et al. · 2012 · Annals of the Rheumatic Diseases
- The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer DevelopmentDuo Zheng, Ann M. Bode, Qing Jie Zhao, Yong‐Yeon Cho, Feng Zhu, Wei-Ya Ma, Zigang Dong · 2008 · Cancer Research
- Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE ConsortiumMorgan A. Marks, Anil K. Chaturvedi, Karl T. Kelsey, Kurt Straíf, Julien Berthiller, Stephen M. Schwartz, Elaine Smith, Annah B. Wyss, Paul Brennan, Andrew F. Olshan et al. · 2013 · Cancer Epidemiology Biomarkers & Prevention
- Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and punctureCassol-Jr, Omar J., Comim, Clarissa M., Silva, Bruno R., Hermani, Fernanda V., Constantino, Larissa S., Felisberto, Francine, Petronilho, Fabricia, Hallak, Jaime Eduardo C., De Martinis, Bruno S., Zuardi, Antonio W. et al. · 2010 · Brain Research
- Microfluidics for nanomedicines manufacturing: An affordable and low-cost 3D printing approachMattia Tiboni, Massimiliano Tiboni, Alessio Pierro, Marco Papa, Simone Sparaventi, Marco Cespi, Luca Casettari · 2021 · International Journal of Pharmaceutics
- Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosisJ. Ludovic Croxford, Gareth Pryce, Samuel J. Jackson, Catherine A. Ledent, Gavin Giovannoni, Roger G. Pertwee, Takashi Yamamura, David Baker · 2007 · Journal of Neuroimmunology
- Cannabinoid system in the skin – a possible target for future therapies in dermatologyPiotr Kupczyk, Adam Reich, Jacek Cezary Szepietowski · 2009 · Experimental Dermatology
- Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old ratsYannick Marchalant, Francesca Cerbai, Holly M. Brothers, Gary L. Wenk · 2007 · Neurobiology of Aging
- The endogenous cannabinoid system in the gut of patients with inflammatory bowel diseaseAntonio Di Sabatino, Natalia Battista, Paolo Biancheri, Cinzia Rapino, Laura Rovedatti, Giuseppe Astarita, Alessandro Vanoli, Enrico Dainese, M. Guerci, Daniele Piomelli et al. · 2011 · Mucosal Immunology
- JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilitiesRobert J. Chorvat, Jennifer Berbaum, Kristine Seriacki, John F. McElroy · 2012 · Bioorganic & Medicinal Chemistry Letters
- Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical UseNicoleta Mirela Blebea, Andreea Iulia Pricopie, Robert-Alexandru Vlad, Gabriel Hancu · 2024 · International Journal of Molecular Sciences
- Cannabis smoking and respiratory health: Consideration of the literaturePeter Gates, Adam Jaffé, Jan Copeland · 2014 · Respirology
- Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammationYannick Marchalant, Susanna Rosi, Gary L. Wenk · 2006 · Neuroscience
- Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironmentGabriele D’Uva, Denisa Baci, Adriana Albini, Douglas McClain Noonan · 2017 · Cancer Treatment Reviews
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptorsMaheswari Rajasekaran, Lisa K. Brents, Lirit N. Franks, Jeffery H. Moran, Paul L. Prather · 2013 · Toxicology and Applied Pharmacology
- Endocannabinoids and pregnancy.Taylor, Anthony H., Amoako, Akwasi A., Bambang, Katerina, Karasu, Tulay, Gebeh, Alpha, Lam, Patricia M.W., Marzcylo, Timothy H., Konje, Justin C. · 2010 · Clinica Chimica Acta
- Opportunities for cannabis in supportive care in cancerA. Kleckner, I. Kleckner, C. Kamen, M. Tejani, M. Janelsins, G. Morrow, L. Peppone · 2019 · Therapeutic Advances in Medical Oncology
- Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARαMustafa A. Karwad, Tara Macpherson, Bo Wang, Elena Theophilidou, Sarir Sarmad, David A. Barrett, Michael Larvin, Karen L. Wright, Jonathan N. Lund, Saoirse Elizabeth O’Sullivan · 2016 · The FASEB Journal
- Therapeutics for neonatal brain injuryFernando F. Gonzalez, Donna Marie Ferriero · 2008 · Pharmacology & Therapeutics
- Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating EndometriosisMahaut Leconte, Carole Nicco, Charlotte Ngô, Sylviane Arkwright, Christiane Chéreau, Jean Guibourdenche, Bernard J. Weill, Charles Chapron, Bertrand E. Dousset, Frédéric Batteux · 2010 · American Journal Of Pathology
- It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health BasketsSeyed Alireza Salami, Federico Martinelli, Antonio Giovino, Ava Bachari, Neda Arad, Nitin L. Mantri · 2020 · Molecules
- Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphomaJenny Flygare, Kristin Gustafsson, Eva K. Kimby, Birger Christensson, Birgitta Sander · 2005 · FEBS Letters
- Interaction between Cannabinoid System and Toll-Like Receptors Controls InflammationKathleen L. McCoy · 2016 · Mediators of Inflammation
- Drug discovery and development with plant-derived compoundsOlivier Potterat, Matthias O. Hamburger · 2007 · Birkhäuser Basel eBooks
- Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cellsEwa Kozela, Ana Juknat, Fuying Gao, Nathali Kaushansky, Giovanni Coppola, Zvi Vogel · 2016 · Journal of Neuroinflammation
- Cannabinoids as Key Regulators of Inflammasome Signaling: A Current PerspectiveSantosh V. Suryavanshi, Igor Kovalchuk, Olga Kovalchuk · 2021 · Frontiers in Immunology
- Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivoTheodore A. Sarafian, Nancy A. Habib, Michael J. Oldham, Navindra Persaud Seeram, Ru‐Po Lee, Laura Lin, Donald P. Tashkin, Michael D. Roth · 2006 · American Journal of Physiology-Lung Cellular and Molecular Physiology
- Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPKYoung Sun Hwang, Youn‐Jung Kim, Mi‐Ok Kim, Mingyeong Kang, Sae Woong Oh, Youn Hwa Nho, See‐Hyoung Park, Jongsung Lee · 2017 · Chemico-Biological Interactions
- Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion MoleculesYan Zhao, Zuyi Yuan, Yan Liu, Jiahong Xue, Yuling Tian, Weimin Liu, Weiping Zhang, Yan Shen, Wei Xu, Xiao Liang et al. · 2010 · Journal of Cardiovascular Pharmacology
- Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosisSieglinde Marquart, Pawel Zerr, Alfiya Akhmetshina, Katrin Palumbo, Nicole Reich, Michal Tomčík, Angelika Horn, Clara Dees, Matthias Engel, Jochen Zwerina et al. · 2010 · Arthritis & Rheumatism
- Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammationGopinath Krishnan, Nivedita Chatterjee · 2012 · Glia
- Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritisGui, Huan, Liu, Xia, Wang, Zhi-Wei, He, Dong-Yi, Su, Ding-Feng, Dai, Sheng-Ming · 2014 · Rheumatology
- Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptorsEvelyn Gaffal, Mira Cron, Nicole Glodde, Thomas Tüting · 2013 · Allergy
- Endocannabinoids: Effectors of glucocorticoid signalingGeorgia Balsevich, Gavin N. Petrie, Matthew N. Hill · 2017 · Frontiers in Neuroendocrinology
- Neuroprotection in the Newborn InfantFernando F. Gonzalez, Donna Marie Ferriero · 2009 · Clinics in Perinatology
- Cannabinoid receptors in acute and chronic complications of atherosclerosisFrançois Mach, Fabrizio Montecucco, Sabine Steffens · 2007 · British Journal of Pharmacology
- The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn RatsDavid Fernández‐López, María Ruth Pazos, Rosa Maria Tolón, María Ángeles Moro, Julián Romero, Ignacio Lizasoaín, José Antonio Martínez-Orgado · 2007 · Pediatric Research
- Combined effects of HIV and marijuana use on neurocognitive functioning and immune statusApril Denise Thames, Zanjbeel Mahmood, Alison C. Burggren, Ahoo Karimian, Taylor P. Kuhn · 2015 · AIDS Care
- CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s DiseaseJeremy L. Koppel, Valérie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy T. Jimenez, Mark Stauber, Rachel Friedman, Peter Davies · 2013 · Molecular Medicine
- Pharmacological Synergism Between Cannabinoids and Paclitaxel in Gastric Cancer Cell LinesHideyo Miyato, Joji Kitayama, Hiroharu Yamashita, Daisuke Souma, Masahiro Asakage, Jun Yamada, Hirokazu Nagawa · 2008 · Journal of Surgical Research
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in MiceKun Li, Jia‐Yan Feng, Yongyu Li, Birol Yuece, Xuhong Lin, Liang-ying Yu, Yanna Li, Ya-jing Feng, Martin Storr · 2012 · Pancreas
- Type-2 cannabinoid receptors in neurodegenerationTiziana Bisogno, Sergio Oddi, Alessandra Piccoli, Domenico Fazio, Mauro Maccarrone · 2016 · Pharmacological Research
- WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cellsA M Wasik, Stefan Almestrand, X Wang, Kjell R. Hultenby, Å-L Dackland, P Andersson, Eva K. Kimby, Birger Christensson, Birgitta Sander · 2011 · Cell Death and Disease
- Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxisKaren Coopman, Laura D. Smith, Karen L. Wright, Stephen Geoffrey Ward · 2006 · International Immunopharmacology
- Cannabinoids in acute gastric damage and pancreatitis.ARTUR B. DEMBINSKI, Zygmunt Warzecha, Piotr Ceranowicz, M Dembiński, Jakub Cieszkowski, Wiesław W. Pawlik, Stanislaw Jan Konturek, Romana Tomaszewska, Waldemar Hładki, Peter Ch Konturek · 2006 · PubMed
- Cannabinoid control of neuroinflammation related to multiple sclerosisDavid Baker, S J Jackson, Gareth Pryce · 2007 · British Journal of Pharmacology
- Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune ResponsesValerio Chiurchiù, Alessandro Leuti, Mauro Maccarrone · 2015 · Journal of Neuroimmune Pharmacology
- Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammationLucile Vincent, Derek Vang, Julia Nguyen, B.A. Benson, Jing-Xuan Lei, Kalpna Gupta · 2015 · Haematologica
- Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila InfectionTangying Lu, Cathy A. Newton, Izabella Perkins, Herman P. Friedman, Thomas Klein · 2006 · Journal of Pharmacology and Experimental Therapeutics
- Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysisAaron Gazendam, Nicholas W. Nucci, Kyle Gouveia, Hassaan Abdel Khalik, Luc Rubinger, Herman S. Johal · 2020 · Cannabis and Cannabinoid Research
- A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situYuval Ramot, Koji Sugawara, Nóra Zákány, Balázs István Tóth, Tamás Bı́ró, Ralf Paus · 2013 · PeerJ
- CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial SepsisBalázs Csóka, Zoltán H. Németh, Partha Mukhopadhyay, Zoltán Spolarics, Mohanraj Rajesh, Stephanie Federici, Edwin A. Deitch, Sándor Bátkai, Pál Pacher, György Haskó · 2009 · PLoS ONE
- Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIVCaitlin Wei‐Ming Watson, Emily W. Paolillo, Erin E. Morgan, Anya Umlauf, Erin E. Sundermann, Ronald J. Ellis, Scott Lee Letendre, Thomas D. Marcotte, Robert K. Heaton, Igor Grant · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
- Peroxisomal and Microsomal Lipid Pathways Associated with Resistance to Hepatic Steatosis and Reduced Pro-inflammatory StateDiana Hall, Carine Poussin, Vidya Velagapudi, Christophe Empsen, Magali Joffraud, Jacques Samuel Beckmann, Albert E. Geerts, Yann Ravussin, Mark R. Ibberson, Matej Orešič et al. · 2010 · Journal of Biological Chemistry
- Glucocorticoids: Dr. Jekyll and Mr. Hyde of Hippocampal NeuroinflammationAlexey P. Bolshakov, Liya V. Tret’yakova, Alexey A. Kvichansky, Natalia V. Gulyaeva · 2021 · Biochemistry (Moscow)
- In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoidsMichelle Roche, Michael Diamond, John P. Kelly, David P. Finn · 2006 · Journal of Neuroimmunology
- Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1Verena Juliana Koller, Gerhard J. Zlabinger, Volker Auwärter, Sabine Fuchs, Siegfried Knasmüller · 2013 · Archives of Toxicology
- Expression of cannabinoid receptors type 1 and type 2 in non‐Hodgkin lymphoma: Growth inhibition by receptor activationKristin Gustafsson, Xiao Wang, Denise Severa, Maeve Eriksson, Eva K. Kimby, Mats Merup, Birger Christensson, Jenny Flygare, Birgitta Sander · 2008 · International Journal of Cancer
- Cannabinoid Modulation of Neuroinflammatory DisordersViviane M. Saito, Rafael Machado Rezende, Antônio Lúcio Teixeira · 2012 · Current Neuropharmacology
- Endocannabinoids in endocrine and related tumoursMaurizio Bifulco, Anna Maria Malfitano, Simona Pisanti, Chiara Laezza · 2008 · Endocrine Related Cancer
- A Population-Based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell CarcinomaCaihua Liang, Michael D. McClean, Carmen J. Marsit, Brock C. Christensen, Edward S. Peters, Heather H. Nelson, Karl T. Kelsey · 2009 · Cancer Prevention Research
- Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblastsGarcia-Gonzalez, E., Selvi, E., Balistreri, E., Lorenzini, S., Maggio, R., Natale, M.-R., Capecchi, P.-L., Lazzerini, P.-E., Bardelli, M., Laghi-Pasini, F. et al. · 2009 · Rheumatology
- A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritisMalek, Natalia, Mrugala, Monika, Makuch, Wioletta, Kolosowska, Natalia, Przewlocka, Barbara, Binkowski, Marcin, Czaja, Martyna, Morera, Enrico, Di Marzo, Vincenzo, Starowicz, Katarzyna · 2015 · Pain
- WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary CultureDiana Aguirre-Rueda, Sol Guerra‐Ojeda, Martı́n Aldasoro, Antonio Iradi, Elena Obrador, María Dolores Mauricio, José M. Vila, Patricia Marchio, Soraya L. Vallés · 2015 · PLoS ONE
- Cannabinoid Receptor 2 (CB2) Mediates Immunoglobulin Class Switching from IgM to IgE in Cultures of Murine-Purified B LymphocytesMarisela Agudelo, Cathy A. Newton, Ray H. Widen, Tracy A. Sherwood, Liang Nong, Herman P. Friedman, Thomas Klein · 2007 · Journal of Neuroimmune Pharmacology
- CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila InfectionCatherine A. Newton, Ping-Jen Chou, Izabella Perkins, Thomas Klein · 2008 · Journal of Neuroimmune Pharmacology
- Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseasesAriane Mallat, Fatima Teixeira-Clerc, Vanessa Deveaux, Sophie Lotersztajn · 2007 · Expert Opinion on Therapeutic Targets
- Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in SepsisJoel Sardinha, Michael Eamon Kelly, Juan Zhou, Christine Lehmann · 2014 · Mediators of Inflammation
- Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammationAndrea Mastinu, Marika Premoli, Giulia Ferrari‐Toninelli, Simone Tambaro, Giuseppina Maccarinelli, Maurizio Memo, Sara Anna Bonini · 2018 · Hormone Molecular Biology and Clinical Investigation
- Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and bloodRonald J. Ellis, Scott N. Peterson, Yueling Li, Rachel D. Schrier, Jenny Iudicello, Scott Lee Letendre, Erin E. Morgan, Bin Tang, Igor Grant, Mariana Cherner · 2020 · Neurology Neuroimmunology & Neuroinflammation
- New trends for the medical treatment of endometriosisRocha, Ana Luiza L, Reis, Fernando M, Petraglia, Felice · 2012 · Expert Opinion on Investigational Drugs
- Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritisGui, Huan, Liu, Xia, Liu, Li-Rong, Su, Ding-Feng, Dai, Sheng-Ming · 2015 · Immunobiology
- A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A ReceptorsCarolina Echeverry, Giselle Prunell, Camila Narbondo, Verónica Sánchez de Medina, Xavier Nadal, Miguel Iván Reyes-Parada, Cecilia Scorza · 2020 · Neurotoxicity Research
- Effects of palmitoylation of Cys415in helix 8 of the CB1cannabinoid receptor on membrane localization and signallingSergio Oddi, Enrico Dainese, Simone Laura Sandiford, Filomena Fezza, Mirko Lanuti, Valerio Chiurchiù, Antonio Totaro, Giuseppina Catanzaro, Daniela Barcaroli, Vincenzo De Laurenzi et al. · 2011 · British Journal of Pharmacology
- Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cellsEwa Kozela, Ana Juknat, Nathali Kaushansky, Avraham Ben‐Nun, Giovanni Coppola, Zvi Vogel · 2015 · Journal of Neuroinflammation
- CB 2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthmaMaria E. Ferrini, Sooyeon Hong, Andrea A. Stierle, Donald B. Stierle, Nephi Stella, K Roberts, Zeina H Jaffar · 2016 · Allergy
- Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid systemKatarzyna Starowicz, Barbara Przewłocka · 2012 · Philosophical Transactions of the Royal Society B Biological Sciences
- Lipopolysaccharide and cyclic AMP regulation of CB2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophagesSomnath Mukhopadhyay, Sucharita Das, Evelyn A. Williams, Duane Moore, Jenelle D. Jones, Daniel S. Zahm, Michael M. Ndengele, Andrew J. Lechner, Allyn C. Howlett · 2006 · Journal of Neuroimmunology